Sahasrabudhe DM - Search Results

1

Lethality-based selection of recombinant genes in mammalian cells: application to identifying tumor antigens.

Smith ES, Mandokhot A, Evans EE, Mueller L, Borrello MA, Sahasrabudhe DM, Zauderer M. Smith ES, et al. Among authors: sahasrabudhe dm. Nat Med. 2001 Aug;7(8):967-72. doi: 10.1038/91017. Nat Med. 2001. PMID: 11479631

2

C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.

Evans EE, Henn AD, Jonason A, Paris MJ, Schiffhauer LM, Borrello MA, Smith ES, Sahasrabudhe DM, Zauderer M. Evans EE, et al. Among authors: sahasrabudhe dm. Mol Cancer Ther. 2006 Nov;5(11):2919-30. doi: 10.1158/1535-7163.MCT-06-0389. Mol Cancer Ther. 2006. PMID: 17121940

3

Shared T cell-defined antigens on independently derived tumors.

Sahasrabudhe DM, Burstyn D, Dusel JC, Hibner BL, Collins JL, Zauderer M. Sahasrabudhe DM, et al. J Immunol. 1993 Dec 1;151(11):6302-10. J Immunol. 1993. PMID: 8245469

4

In vitro generation of tumor specific T cells that recognize a shared antigen of AML: molecular characterization of TCR genes.

Coppage M, Belanger T, Zauderer M, Sahasrabudhe D. Coppage M, et al. Leuk Res. 2007 Feb;31(2):195-202. doi: 10.1016/j.leukres.2006.04.007. Epub 2006 Jun 5. Leuk Res. 2007. PMID: 16750565

5

Inhibition of suppressor T lymphocytes by murine interferon beta.

Sahasrabudhe DM. Sahasrabudhe DM. J Exp Med. 1987 Nov 1;166(5):1573-8. doi: 10.1084/jem.166.5.1573. J Exp Med. 1987. PMID: 2960771 Free PMC article.

6

Suppression of delayed type hypersensitivity by desferoxamine.

Sahasrabudhe DM, Dusel J, Jedlika S. Sahasrabudhe DM, et al. J Immunother (1991). 1991 Apr;10(2):112-9. doi: 10.1097/00002371-199104000-00005. J Immunother (1991). 1991. PMID: 2043591

7

Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.

Woodlock TJ, Sahasrabudhe DM, Marquis DM, Greene D, Pandya KJ, McCune CS. Woodlock TJ, et al. Among authors: sahasrabudhe dm. J Immunother. 1999 May;22(3):251-9. doi: 10.1097/00002371-199905000-00008. J Immunother. 1999. PMID: 10335485 Clinical Trial.

8

Effect of murine interferon alpha/beta on tumour-induced suppressor function.

Sahasrabudhe DM, Dusel JC. Sahasrabudhe DM, et al. Cancer Immunol Immunother. 1994 Dec;39(6):360-6. doi: 10.1007/BF01534422. Cancer Immunol Immunother. 1994. PMID: 8001023 Free PMC article.

9

Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.

Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM. Khorana AA, et al. Among authors: sahasrabudhe dm. Cancer. 2003 Feb 15;97(4):960-8. doi: 10.1002/cncr.11152. Cancer. 2003. PMID: 12569594 Free article.

10

Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals.

Ou Z, Wang Y, Chen J, Tao L, Zuo L, Sahasrabudhe D, Joseph J, Wang L, Yeh S. Ou Z, et al. Exp Mol Med. 2018 Nov 20;50(11):1-11. doi: 10.1038/s12276-018-0155-5. Exp Mol Med. 2018. PMID: 30459405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters